LASRY MARC
13F Reported Value
ⓘ$15.1M
Holdings
9
Latest Filing
2025-09-30
Filing Quarter
Q3 2025
Portfolio Overview
LASRY MARC disclosed 9 positions worth $15.1M in its Form 13F-HR for Q3 2025, led by $XBP (XBP Global Holdings, Inc.) at 64.9% of the equity portfolio, followed by $HYPD and $NEXT. During the quarter the fund opened 3 new positions and exited 2 — including a new stake in $XBP and a full exit from $PDD. The portfolio is most concentrated in Industrials (64.9% of disclosed assets). All figures are sourced directly from LASRY MARC’s Form 13F-HR filing with the SEC under CIK 1259927.
AI Fund Analysis
StableSector Allocation
AUM History
Top Equity Holdings by Value
Quarterly Activity — Q3 2025
Click any card to unlockTop Holdings
- 32.5#2,261
Quality
$9.8M12,107,907 sh - —
Quality
$2.3M240,124 sh - —
Quality
$1.7M254,270 sh - 18.9
Quality
$403.3K23,246 sh - —
Quality
$293.7K101,638 sh - 25.2
Quality
$192.0K11,363 sh - —
Quality
$189.3K81,950 sh - 8.7
Quality
$151.0K60,869 sh - $31.4K62,887 sh
| Company | Quality | Value | Shares |
|---|---|---|---|
 XBP Global Holdings, Inc.$XBP | 32.5#2,261 | $9.8M | 12,107,907 |
 HYPERION DEFI, INC.$HYPD | — | $2.3M | 240,124 |
 NextDecade Corp$NEXT | — | $1.7M | 254,270 |
 DarioHealth Corp.$DRIO | 18.9 | $403.3K | 23,246 |
 Valion Bio, Inc.$VBIO | — | $293.7K | 101,638 |
 Forge Global Holdings, Inc.$FRGE | 25.2 | $192.0K | 11,363 |
 Beyond Air, Inc.$XAIR | — | $189.3K | 81,950 |
 Orchestra BioMed Holdings, Inc.$OBIO | 8.7 | $151.0K | 60,869 |
 Rani Therapeutics Holdings, Inc.$RANI | — | $31.4K | 62,887 |
Unlock AI quality scores for every holding
32-signal composite ranking on each of LASRY MARC's 9 positions.
Showing top 9 of 9 holdings.
Sector Allocation
Industrials
$9.8M
Healthcare
$3.4M
Energy
$1.7M
Financials
$192,035
Full Holdings — LASRY MARC (Q3 2025)
All 9 disclosed positions from the latest Form 13F-HR, with quarter-over-quarter share changes and 13F Pro quality scores. Sourced from SEC EDGAR.
| # | Ticker | Company | Value | Weight | QoQ | Quality |
|---|---|---|---|---|---|---|
| 1 | $XBP | XBP Global Holdings, Inc. | $9.8M | 64.9% | NEW | 32.5 |
| 2 | $HYPD | HYPERION DEFI, INC. | $2.3M | 15.3% | NEW | — |
| 3 | $NEXT | NextDecade Corp | $1.7M | 11.5% | +0% | — |
| 4 | $DRIO | DarioHealth Corp. | $403,318 | 2.7% | -95% | 18.9 |
| 5 | $VBIO | Valion Bio, Inc. | $293,734 | 1.9% | NEW | — |
| 6 | $FRGE | Forge Global Holdings, Inc. | $192,035 | 1.3% | +0% | 25.2 |
| 7 | $XAIR | Beyond Air, Inc. | $189,305 | 1.3% | -95% | — |
| 8 | $OBIO | Orchestra BioMed Holdings, Inc. | $150,955 | 1.0% | +0% | 8.7 |
| 9 | $RANI | Rani Therapeutics Holdings, Inc. | $31,431 | 0.2% | +0% | — |
New Positions (3)
Exited Positions (2)
$PDD PDD Holdings Inc.Browse Top Institutional Investors
13F Pro tracks 8,700+ institutional investors filing 13F reports with the SEC.
to search all 8,700+ institutional filers.
Available Analysis
13F Pro tracks comprehensive institutional data for LASRY MARC including:
Track LASRY MARC's Full Portfolio
See every holding, quarter-over-quarter changes, sector allocation, and accumulation patterns for LASRY MARC and 8,700+ other institutional investors.
Free tier includes full 13F search and fund profiles. Pro starts at $6.67/mo (billed annually).
AI-Powered Hedge Fund Analysis: LASRY MARC
13F Pro is an AI hedge fund tracker and stock research platform. For LASRY MARC (SEC CIK: 1259927), the platform ingests every quarterly Form 13F filing and applies AI-powered analysis on top — 10 specialized AI analysts (value, growth, momentum, macro, activist, and more) debate the fund's top positions and publish AI-generated analysis with cited SEC sources.
Every holding in LASRY MARC's portfolio is scored on a 32-signal AI quality ranking (ROIC, FCF margin, revenue growth, institutional flow, earnings quality, shareholder dilution, and more). Track accumulation and distribution quarter over quarter, identify conviction positions, and see AI stock analysis for each position — alongside 8,700+ other institutional filers and 2,800+ AI-ranked companies.